Colgate-Palmolive (CL)

Colgate-Palmolive on one page: short interest, daily short volume, fails to deliver, planned sales, large holders, 13F holders, financials, earnings dates and insider trades. Listed on NYSE, classified by the SEC as perfumes, cosmetics & other toilet preparations.

Download CSV

24.0M

Short interest

settlement 2026-09-30

4.0

Days to cover

unchanged vs prior

49.5%

Short share of volume

2026-10-09

Fails to deliver

settlement 2026-09-11

Fri 30 Oct

Next earnings

estimated date

-$31.0M

Insider flow, 90 days

0 buys, 4 sells

As of 2026-10-09.

Short interest

FINRA, twice a month. The newest 24 settlements in the table, 48 in the chart. JSON

As of 30 September 2026, short interest in CL is 24,041,443 shares, up 6,870,128 shares over the last month. Over the last 48 readings it ranged from 8,913,925 shares (29 November 2024) to 24,041,443 shares (30 September 2026). The latest reading sits at the top of that range. At the reported average volume of 6.0M shares a day that is 4.0 days to cover.

Embed this chart.The embed keeps its attribution line.

<iframe src="https://xoomar.com/embed/stocks/cl" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>

Preview Dark previewAdd ?theme=dark to the src for a dark chart.

Settlement	Shares short	Change	Avg daily volume	Days to cover
2026-09-30	24,041,443	+30.7%	6,000,090	4.01
2026-09-15	18,399,416	+7.2%	4,606,543	3.99
2026-08-31	17,171,315	-2.2%	4,116,436	4.17
2026-08-14	17,557,432	-1.2%	4,342,787	4.04
2026-07-31	17,767,107	+6.3%	4,627,400	3.84
2026-07-15	16,716,514	-4.6%	4,332,104	3.86
2026-06-30	17,529,142	-14.6%	6,122,523	2.86
2026-06-15	20,530,776	-2.9%	5,430,738	3.78
2026-05-29	21,136,595	+6.6%	5,092,536	4.15
2026-05-15	19,836,043	+15.0%	5,394,746	3.68
2026-04-30	17,253,640	-11.1%	5,297,196	3.26
2026-04-15	19,407,937	-9.1%	5,227,647	3.71
2026-03-31	21,358,365	+5.0%	7,020,121	3.04
2026-03-13	20,343,940	+4.1%	6,810,220	2.99
2026-02-27	19,539,470	+17.8%	6,172,061	3.17
2026-02-13	16,589,065	+8.6%	7,476,131	2.22
2026-01-30	15,274,525	-6.5%	7,694,740	1.99
2026-01-15	16,341,336	+13.1%	7,543,276	2.17
2025-12-31	14,453,331	+6.9%	5,102,275	2.83
2025-12-15	13,516,071	-5.5%	6,539,071	2.07
2025-11-28	14,296,299	+0.2%	5,509,380	2.59
2025-11-14	14,262,439	+4.0%	7,675,992	1.86
2025-10-31	13,712,844	-11.0%	7,423,742	1.85
2025-10-15	15,401,100	+10.8%	6,216,713	2.48

Daily short volume

FINRA Reg SHO, the last 30 sessions. JSON

As of 9 October 2026, the short share of CL volume is 49.5%, down 0.8 points over the last five sessions. Over the last 30 readings it ranged from 41.4% (28 August 2026) to 68.1% (25 September 2026). The latest reading is 8.6 points below the 30-session average of 58.2%, on 1.1M shares reported.

Date	Short volume	Total volume	Short share	Exempt
2026-10-09	547K	1.1M	49.5%	790
2026-10-08	876K	1.3M	66.6%	1,513
2026-10-07	813K	1.5M	54.5%	1,337
2026-10-06	765K	1.2M	61.2%	1,549
2026-10-05	1.3M	2.0M	64.1%	8,710
2026-10-02	885K	1.8M	50.3%	1,390
2026-10-01	899K	1.7M	51.8%	879
2026-09-30	818K	1.3M	62.7%	2,724
2026-09-29	624K	1.1M	58.2%	2,516
2026-09-28	539K	1.1M	50.4%	108
2026-09-25	864K	1.3M	68.1%	2,770
2026-09-24	1.1M	1.7M	66.1%	1,738
2026-09-23	1.1M	1.7M	64.6%	6,099
2026-09-22	804K	1.3M	61.6%	1,244
2026-09-21	1.0M	1.7M	61.7%	11,307
2026-09-18	727K	1.1M	66.9%	485
2026-09-17	863K	1.4M	63.6%	263
2026-09-16	732K	1.2M	59.9%	2,010
2026-09-15	987K	1.7M	59.7%	1,329
2026-09-14	623K	1.2M	52.1%	1,791
2026-09-11	1.1M	1.9M	58.1%	445
2026-09-10	789K	1.2M	65.0%	790
2026-09-09	785K	1.4M	56.8%	667
2026-09-08	737K	1.4M	52.4%	5,637
2026-09-04	752K	1.4M	55.1%	480
2026-09-03	857K	1.7M	50.5%	2
2026-09-02	869K	1.5M	58.7%	776
2026-09-01	764K	1.4M	52.9%	44
2026-08-31	961K	1.6M	60.3%	132
2026-08-28	438K	1.1M	41.4%	696

Fails to deliver

SEC, the last 30 settlement dates with a fail. JSON

As of 11 September 2026, the fails-to-deliver balance in CL is 12 shares, up 3 shares over the last settlement date. Over the last 30 readings it ranged from 1 share (3 June 2026) to 101,952 shares (10 June 2026). The latest reading sits at the bottom of that range.

Settlement	Shares failed	Price	Value
2026-09-11	12	$87.90	$1K
2026-09-01	9	$89.82	$808
2026-08-28	119	$90.96	$11K
2026-08-04	23,370	$89.88	$2.1M
2026-07-31	29	$91.60	$3K
2026-07-20	1,956	$92.98	$182K
2026-07-17	1	$94.07	$94
2026-07-13	26,498	$92.24	$2.4M
2026-07-06	58	$95.13	$6K
2026-07-02	26,938	$92.76	$2.5M
2026-06-30	15,611	$92.40	$1.4M
2026-06-29	1,400	$92.07	$129K
2026-06-23	1,984	$88.67	$176K
2026-06-22	34,415	$89.48	$3.1M
2026-06-18	586	$90.58	$53K
2026-06-10	101,952	$87.80	$9.0M
2026-06-03	1	$88.27	$88
2026-05-20	145	$90.02	$13K
2026-05-18	536	$88.13	$47K
2026-05-13	6	$87.44	$525
2026-05-01	868	$85.36	$74K
2026-04-30	1,817	$84.49	$154K
2026-04-29	1,114	$85.67	$95K
2026-04-15	9	$84.16	$757
2026-04-14	5,091	$83.98	$428K
2026-03-25	81	$84.53	$7K
2026-03-23	100	$85.12	$9K
2026-03-06	183	$92.67	$17K
2026-02-27	3	$97.55	$293
2026-02-23	31,546	$95.09	$3.0M

Insider trades

SEC Form 4, newest first, 50 of 100 shown. JSON

Insiders at CL reported 4 open-market sells worth $31.0M in the last 90 days and no open-market buys. Latest filing: NORRINGTON LORRIE M (Director) on 2026-10-01.

Date	Insider	Title	Type	Shares	Price	Value	Owned after
2026-10-01	NORRINGTON LORRIE M	Director	Grant	300	$87.42	$26K	43K
2026-10-01	Newman Brian	Director	Grant	214	$87.42	$19K	8K
2026-10-01	BILBREY JOHN P	Director	Grant	271	$87.42	$24K	41K
2026-09-16	Wallace Noel R.	Chairman, President & CEO	Grant	30K	$0.00	$0	380K
2026-09-16	GRANT SHANE	COO, Americas	Grant	7K	$0.00	$0	80K
2026-09-16	Tsourapas Panagiotis	COO, CD, EMEA, APac, Skin	Grant	5K	$0.00	$0	11K
2026-09-16	SUTULA STANLEY J III	Chief Financial Officer	Grant	8K	$0.00	$0	79K
2026-09-16	Hazlin John	Chief Growth Officer	Grant	4K	$0.00	$0	27K
2026-09-16	Massey Sally	Chief People Officer	Grant	3K	$0.00	$0	15K
2026-09-16	Fishbone Betsy	CLO and Secretary	Grant	2K	$0.00	$0	16K
2026-09-16	Malcolm Gregory	EVP and Controller	Grant	1K	$0.00	$0	14K
2026-09-13	Wallace Noel R.	Chairman, President & CEO	Tax withholding	5K	$86.80	$425K	350K
2026-09-13	Tsourapas Panagiotis	COO, CD, EMEA, APac, Skin	Tax withholding	922	$86.80	$80K	7K
2026-09-13	SUTULA STANLEY J III	Chief Financial Officer	Tax withholding	1K	$86.80	$120K	71K
2026-09-13	Massey Sally	Chief People Officer	Tax withholding	686	$86.80	$60K	12K
2026-09-13	Malcolm Gregory	EVP and Controller	Tax withholding	225	$86.80	$20K	13K
2026-09-13	Hazlin John	Chief Growth Officer	Tax withholding	499	$86.80	$43K	23K
2026-09-13	Fishbone Betsy	CLO and Secretary	Tax withholding	472	$86.80	$41K	14K
2026-09-12	Wallace Noel R.	Chairman, President & CEO	Tax withholding	4K	$86.80	$305K	355K
2026-09-12	Tsourapas Panagiotis	COO, CD, EMEA, APac, Skin	Tax withholding	618	$86.80	$54K	8K
2026-09-12	SUTULA STANLEY J III	Chief Financial Officer	Tax withholding	927	$86.80	$80K	72K
2026-09-12	Massey Sally	Chief People Officer	Tax withholding	459	$86.80	$40K	13K
2026-09-12	Malcolm Gregory	EVP and Controller	Tax withholding	151	$86.80	$13K	13K
2026-09-12	Hazlin John	Chief Growth Officer	Tax withholding	439	$86.80	$38K	24K
2026-09-12	Fishbone Betsy	CLO and Secretary	Tax withholding	331	$86.80	$29K	14K
2026-09-11	Wallace Noel R.	Chairman, President & CEO	Tax withholding	4K	$86.80	$353K	358K
2026-09-11	Tsourapas Panagiotis	COO, CD, EMEA, APac, Skin	Tax withholding	684	$86.80	$59K	8K
2026-09-11	SUTULA STANLEY J III	Chief Financial Officer	Tax withholding	1K	$86.80	$104K	73K
2026-09-11	Massey Sally	Chief People Officer	Tax withholding	651	$86.80	$57K	13K
2026-09-11	Malcolm Gregory	EVP and Controller	Tax withholding	167	$86.80	$14K	13K
2026-09-11	Hazlin John	Chief Growth Officer	Tax withholding	649	$86.80	$56K	24K
2026-09-11	GRANT SHANE	COO, Americas	Tax withholding	622	$86.80	$54K	72K
2026-09-11	Fishbone Betsy	CLO and Secretary	Tax withholding	404	$86.80	$35K	15K
2026-08-24	Tsourapas Panagiotis	COO, CD, EMEA, APac, Skin	Sell	10K	$92.05	$920K	65K
2026-08-06	CAHILL JOHN T	Director	Sell	4K	$93.37	$389K	28K
2026-08-06	CAHILL JOHN T	Director	Option exercise	4K	$71.56	$298K	33K
2026-08-05	Wallace Noel R.	Chairman, President & CEO	Sell	161K	$92.52	$14.9M	362K
2026-08-05	Wallace Noel R.	Chairman, President & CEO	Option exercise	161K	$72.29	$11.6M	523K
2026-08-04	Wallace Noel R.	Chairman, President & CEO	Sell	161K	$91.92	$14.8M	362K
2026-08-04	Wallace Noel R.	Chairman, President & CEO	Option exercise	161K	$72.29	$11.6M	523K
2026-07-01	NORRINGTON LORRIE M	Director	Grant	293	$89.45	$26K	43K
2026-07-01	Newman Brian	Director	Grant	209	$89.45	$19K	8K
2026-07-01	BILBREY JOHN P	Director	Grant	265	$89.45	$24K	40K
2026-06-16	GRANT SHANE	COO, Americas	Tax withholding	23K	$90.66	$2.1M	72K
2026-05-15	Malcolm Gregory	EVP and Controller	Sell	2K	$88.44	$203K	14K
2026-05-11	NORRINGTON LORRIE M	Director	Grant	2K	$0.00	$0	42K
2026-05-11	Newman Brian	Director	Grant	2K	$0.00	$0	8K
2026-05-11	Nelson Kimberly A	Director	Grant	2K	$0.00	$0	12K
2026-05-11	HUNDMEJEAN MARTINA	Director	Grant	2K	$0.00	$0	16K
2026-05-11	HARRIS C MARTIN	Director	Grant	2K	$0.00	$0	25K

Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.

Planned sales (Form 144)

Newest first. JSON

11 Form 144 notices on file for CL worth $53.5M at the prices reported; 5 in the last 90 days worth $31.2M. Latest: Tsourapas Panagiotis filed on 2026-08-24 to sell 10,000 shares ($920K) from 2026-08-24.

Filed	Seller	Shares	Market value	Of outstanding	Sale from	Broker
2026-08-24	Tsourapas PanagiotisOfficer	10K	$920K	0.001%	2026-08-24	Merrill Lynch
2026-08-06	CAHILL JOHN TDirector	4K	$389K	0.001%	2026-08-06	Merrill Lynch
2026-08-05	Wallace Noel R.Officer	161K	$14.9M	0.020%	2026-08-05	Merrill Lynch
2026-08-04	Wallace Noel R.Officer	161K	$14.8M	0.020%	2026-08-04	Merrill Lynch
2026-08-04	CAHILLANE STEVEN AOfficer	2K	$160K	0.000%	2026-08-04	Merrill Lynch
2026-02-12	Tsourapas PanagiotisOfficer	15K	$1.5M	0.002%	2026-02-12	Merrill Lynch
2026-02-11	Tsourapas PanagiotisOfficer	35K	$3.3M	0.004%	2026-02-11	Merrill Lynch
2026-02-10	Hazlin JohnOfficer	21K	$2.0M	0.003%	2026-02-10	Merrill Lynch
2026-02-04	Daniels JenniferOfficer	22K	$2.1M	0.003%	2026-02-04	Merrill Lynch
2026-02-04	Wallace Noel R.Officer, Director	46K	$4.3M	0.006%	2026-02-04	Merrill Lynch
2026-02-04	SUTULA STANLEY J IIIOfficer	98K	$9.2M	0.012%	2026-02-04	Merrill Lynch

Large holders (13D and 13G)

One row per reporting person with its latest filing, newest first. JSON

1 holder reports 5% or more of CL in its latest filing, on Schedule 13G (passive). The holder is Vanguard Capital Management at 7.5% of the class (60,404,276 shares), filed 2026-04-29 for an event on 2026-03-31.

Filed	Form	Holder	Shares	Of class	Event
2026-04-29	13G	Vanguard Capital Managementinvestment adviser	60.4M	7.5%	2026-03-31
2026-03-26	13G/Ano. 13	The Vanguard Groupinvestment adviser	0	0.0%	2026-03-13

13F holders

Tracked managers holding CL at their latest 13F. JSON

9 of the 30 tracked managers held CL at their latest 13F, $1.08B in total at quarter-end prices. AQR Capital Management is the largest at $426.8M (0.1% of its portfolio) as of 2026-06-30. Over the prior quarter 6 added shares and 3 cut.

Fund	Quarter	Shares	Value	Of portfolio	Change in shares
AQR Capital Management	2026-06-30	4.7M	$426.8M	0.15%	+2.9M
Citadel Advisors	2026-06-30	4.6M	$420.3M	0.05%	+1.4M
Millennium Management	2026-06-30	1.3M	$117.0M	0.04%	+535K
Renaissance Technologies	2026-06-30	882K	$80.9M	0.11%	-1.4M
D. E. Shaw & Co.	2026-06-30	158K	$14.5M	0.01%	-321K
Bridgewater Associates	2026-06-30	77K	$7.1M	0.03%	-7K
Point72 Asset Management	2026-06-30	70K	$6.4M	0.01%	new
Fisher Asset Management	2026-06-30	61K	$5.6M	0.00%	+4K
Two Sigma Investments	2026-06-30	61K	$5.6M	0.00%	+57K

Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.

Financials

SEC XBRL, as filed. JSON

In Q2 FY 2026 (quarter ended 2026-06-30) Colgate-Palmolive reported revenue of $5.36B, up 4.9% from the same quarter a year earlier, and net income of $693.0M (0.86 diluted EPS). In FY 2025 it generated $4.20B of operating cash flow and spent $1.21B on buybacks. As of 2026-06-30, cash was $1.37B against $7.82B of debt.

Cash: $1.37B
Debt: $7.82B
Equity: $236.0M
Total assets: $16.79B
Shares outstanding: 797,172,829

Quarterly, last 8 quarters

Quarter	Period end	Revenue	Net income	Margin	Diluted EPS
Q2 FY 2026	2026-06-30	$5.36B	$693.0M	12.9%	0.86
Q1 FY 2026	2026-03-31	$5.32B	$646.0M	12.1%	0.80
Q4 FY 2025derived	2025-12-31	$5.23B	-$36.0M	-0.7%	n/a
Q3 FY 2025	2025-09-30	$5.13B	$735.0M	14.3%	0.91
Q2 FY 2025	2025-06-30	$5.11B	$743.0M	14.5%	0.91
Q1 FY 2025	2025-03-31	$4.91B	$690.0M	14.1%	0.85
Q4 FY 2024derived	2024-12-31	$4.95B	$738.0M	14.9%	n/a
Q3 FY 2024	2024-09-30	$5.03B	$737.0M	14.6%	0.90

Fiscal years, with buybacks and dividends

Fiscal year	Ends	Revenue	Net income	Operating cash flow	Capex	Buybacks	Dividends
FY 2025	2025-12-31	$20.38B	$2.13B	$4.20B	$564.0M	$1.21B	n/a
FY 2024	2024-12-31	$20.10B	$2.89B	$4.11B	$561.0M	$1.74B	n/a
FY 2023	2023-12-31	$19.46B	$2.30B	$3.75B	$705.0M	$1.13B	n/a
FY 2022	2022-12-31	$17.97B	$1.78B	$2.56B	$696.0M	$1.31B	n/a
FY 2021	2021-12-31	$17.42B	$2.17B	$3.33B	$567.0M	$1.32B	n/a

Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are the cash the company paid to repurchase its common stock in the year, not the amount authorized. Balance sheet lines are as of 2026-06-30; shares outstanding as of 2026-06-30 from the cover page.

What this page is

Colgate-Palmolive in the regulatory record

Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.

Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.

This page follows Colgate-Palmolive (CL), SEC CIK 21665, listed on NYSE, classified by the SEC as perfumes, cosmetics & other toilet preparations. The cross-market tables live on the short interest and insider transactions hubs.

Source and updates

Short interest: FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-09-30.JSON and CSV
Daily short volume: FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-10-09.JSON and CSV
Fails to deliver: SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-09-11.JSON and CSV
Planned sales: SEC EDGAR Form 144Source: SEC.New notices appear shortly after the SEC posts them; a notice is filed on or before the sale. Latest 2026-08-24.JSON and CSV
Large holders: SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-04-29.JSON and CSV
13F holders: SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
Financials: SEC EDGAR 10-K and 10-Q filingsSource: SEC.Weekly; values are as filed in the 10-Q and 10-K. Latest 2026-06-30.JSON and CSV
Earnings dates: SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-07-31.JSON and CSV
Insider trades: SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-10-01.JSON and CSV
Company record: EDGAR filing index for CIK 21665Ticker, name and exchange from the SEC's company list, refreshed weekly.
Rate limits: 10 requests a minute without a key, 30 with a free key from a free account.

How to read it

Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.

Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.

Other companies the SEC classifies as perfumes, cosmetics & other toilet preparations

Other company pages

Datasets

Frequently Asked Questions

How much of CL is sold short?

24,041,443 shares were held short at the 2026-09-30 settlement, 4.0 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.

What is CL's daily short volume?

On 2026-10-09, 546,567 of the 1,103,677 CL shares reported to FINRA were sold short, 49.5% of the day's reported volume. Short volume is a flow for one day, not a position.

Does CL have fails to deliver?

The SEC's latest file shows 12 CL shares failed to deliver at settlement 2026-09-11. Fails are reported per settlement date and published twice a month with a lag.

Are CL insiders buying or selling?

Insiders at CL reported 4 open-market sells worth $31.0M in the last 90 days and no open-market buys. Latest filing: NORRINGTON LORRIE M (Director) on 2026-10-01.

Have CL insiders filed to sell?

Who owns 5% or more of CL?

What did CL report last quarter?

Which tracked 13F managers own CL?

9 of the 30 tracked 13F managers held CL shares at their latest filing, $1.08B in all. The largest: Cliff Asness's AQR Capital Management (4.7M shares, $426.8M), Ken Griffin's Citadel Advisors (4.6M shares, $420.3M), Izzy Englander's Millennium Management (1.3M shares, $117.0M), Renaissance Technologies (882K shares, $80.9M), D. E. Shaw & Co. (158K shares, $14.5M), Ray Dalio's Bridgewater Associates (77K shares, $7.1M). The table above lists all 9.

Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.